BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2268504)

  • 41. Further characterization of the 5-hydroxytryptamine 5-HT1-like receptor mediating contraction of guinea-pig iliac artery.
    Schoeffter P; Sahin-Erdemli I
    Eur J Pharmacol; 1992 Aug; 219(2):295-301. PubMed ID: 1425955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of 5-hydroxytryptamine receptors in bovine coronary arteries.
    Foy RA; Myles JL; Wilkerson RD
    J Pharmacol Exp Ther; 1992 May; 261(2):601-6. PubMed ID: 1533667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 5-Hydroxytryptamine(1F) receptors do not participate in vasoconstriction: lack of vasoconstriction to LY344864, a selective serotonin(1F) receptor agonist in rabbit saphenous vein.
    Cohen ML; Schenck K
    J Pharmacol Exp Ther; 1999 Sep; 290(3):935-9. PubMed ID: 10454462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence for mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contraction of canine basilar artery.
    Müller-Schweinitzer E; Engel G
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):287-92. PubMed ID: 6664382
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of the thromboxane A2-mimetic U46619 on 5-HT1-like and 5-HT2 receptor-mediated contraction of the rabbit isolated femoral artery.
    MacLennan SJ; Martin GR
    Br J Pharmacol; 1992 Oct; 107(2):418-21. PubMed ID: 1422590
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for a 5-HT1-like receptor mediating the amplifying action of 5-HT in the rabbit ear artery.
    de la Lande IS
    Br J Pharmacol; 1992 Sep; 107(1):550-5. PubMed ID: 1422578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of local anaesthetics on responses of human saphenous vein and bovine coronary artery to neurotransmitters, acetylcholine, noradrenaline and 5-hydroxytryptamine.
    Wali FA
    Gen Pharmacol; 1986; 17(4):405-11. PubMed ID: 2875920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ketanserin causes surmountable antagonism of 5-hydroxytryptamine-induced contractions of large coronary arteries of dog.
    Frenken M; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):301-3. PubMed ID: 3157065
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heterogeneity of 5-HT receptor subtypes in isolated human femoral and saphenous veins.
    Glusa E; Müller-Schweinitzer E
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Feb; 347(2):133-6. PubMed ID: 8474533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues.
    Leff P; Martin GR; Morse JM
    Br J Pharmacol; 1987 Jun; 91(2):321-31. PubMed ID: 3607360
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
    Hamel E; Robert JP; Young AR; MacKenzie ET
    J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of the 5-hydroxytryptamine receptor which mediates contraction of the human isolated basilar artery.
    Parsons AA; Whalley ET
    Cephalalgia; 1989; 9 Suppl 9():47-51. PubMed ID: 2544283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibitory effects of nisoldipine on serotonin and potassium induced contractions of porcine coronary and femoral arteries.
    Kazda S
    Arzneimittelforschung; 1991 Mar; 41(3):204-7. PubMed ID: 1867655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR; Joos GF; Pauwels RA
    Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effect of hypothermia on the vascular tone and reactivity of the human coronary artery and graft vessels.
    Bodelsson M; Arneklo-Nobin B; Chester AH; Tadjkarimi S; Törnebrandt K; Yacoub M
    J Cardiovasc Surg (Torino); 1991; 32(3):288-94. PubMed ID: 2055921
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelium-dependent contractile responses to 5-hydroxytryptamine in the rabbit basilar artery.
    Seager JM; Clark AH; Garland CJ
    Br J Pharmacol; 1992 Feb; 105(2):424-8. PubMed ID: 1532763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serotoninergic receptor subtype in coronary artery smooth muscle from young and atherosclerotic rabbit.
    Félétou M; Dellazuana O; Duhault J
    J Pharmacol Exp Ther; 1994 Jan; 268(1):124-32. PubMed ID: 8301547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Signalling pathways activated by 5-HT(1B)/5-HT(1D) receptors in native smooth muscle and primary cultures of rabbit renal artery smooth muscle cells.
    Hinton JM; Hill P; Jeremy J; Garland C
    J Vasc Res; 2000; 37(6):457-68. PubMed ID: 11146399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 5-Hydroxytryptamine induces contraction in isolated human mammary artery: effect of ketanserin.
    Monopoli A; Conti A; Forlani A; Ongini E; Antona C; Biglioli P
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():59-61. PubMed ID: 2285652
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of 5-HT2 receptors in serotonin-induced contraction in the human mammary artery.
    Conti A; Monopoli A; Forlani A; Ongini E; Antona C; Biglioli P
    Eur J Pharmacol; 1990 Feb; 176(2):207-12. PubMed ID: 2138088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.